IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus (SUGAR-EVE)
This study has been terminated.
(Slow enrollment)
Sponsor:
University of Luebeck
Collaborators:
University of Schleswig-Holstein, Campus Kiel, Germany
Kerckhoff Klinik
Charite University, Berlin, Germany
Information provided by (Responsible Party):
Holger Thiele, University of Luebeck
ClinicalTrials.gov Identifier:
NCT02632292
First received: December 3, 2015
Last updated: April 12, 2017
Last verified: April 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | January 2019 |
| Estimated Primary Completion Date: | April 2018 (Final data collection date for primary outcome measure) |